We are live on ! Find out more
BDR

Blonder Tongue Laboratories Inc

Delisted

BDR was delisted on the 24th of June, 2022.

9 hedge funds and large institutions have $475K invested in Blonder Tongue Laboratories Inc in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more funds holding

Funds holding: 59 (+4)

72% more capital invested

Capital invested by funds: $276K → $475K (+$199K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
9
Holders Change
+4
Holders Change %
+80%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

BDR Hedge Fund Activity: Q3 2014 in Review

9 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Blonder Tongue Laboratories Inc (BDR) for Q3 2014, worth a combined $475K — up 72% from $276K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BDR positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $30K. The largest seller was Citadel Advisors, cutting an estimated $4.42K.

  • 9 institutional investors held Blonder Tongue Laboratories Inc (BDR) as of Q3 2014, up from 5 in Q2 2014.
  • Funds reported $475K of Blonder Tongue Laboratories Inc stock for Q3 2014, up 72% quarter-over-quarter.
  • 4 funds opened new Blonder Tongue Laboratories Inc positions in Q3 2014 and 0 closed out, a net change of +4 holders.
  • The largest Blonder Tongue Laboratories Inc buyer in Q3 2014 was Renaissance Technologies, an estimated $30K added.
  • The largest Blonder Tongue Laboratories Inc seller in Q3 2014 was Citadel Advisors, an estimated $4.42K sold.

Based on aggregated 13F filings for Q3 2014.